SCHEMBL20110000

SCHEMBL20110000

C[Si](C)(C)c1ccc(-c2c3ccccc3c(-c3cccc(-c4ccc5ccccc5c4)c3)c3ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 2/20 0.44
▸ HSD17B2 P37059 2/20 0.44
▸ CYP11B1 P15538 3/20 0.41
▸ CYP11B2 P19099 3/20 0.41
▸ CYP17A1 P05093 1/20 0.41
▸ CYP19A1 P11511 1/20 0.41
▸ ESR1 P03372 5/20 0.41
▸ ESR2 Q92731 4/20 0.41
▸ IKBKB O14920 1/20 0.39
▸ CYP1A2 P05177 4/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CYP3A4 P08684 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13697091 0.94 HSD17B1 (0.44) HSD17B1HSD17B2CYP11B1CYP11B2CYP17A1
SCHEMBL13697096 0.94 HSD17B1 (0.44) HSD17B1HSD17B2CYP11B1CYP11B2CYP17A1
SCHEMBL4084190 0.92 IKBKB (0.42) CYP11B1CYP11B2CYP17A1CYP19A1ESR1
SCHEMBL16690546 0.91 HSD17B1 (0.37) HSD17B1HSD17B2CYP11B1CYP11B2CYP17A1
SCHEMBL13697092 0.91 HSD17B1 (0.39) HSD17B1HSD17B2CYP11B1CYP11B2CYP17A1
SCHEMBL14340316 0.91 ESR1 (0.43) HSD17B1HSD17B2CYP11B1CYP11B2CYP17A1
SCHEMBL23027127 0.90 ESR1 (0.39) HSD17B1HSD17B2CYP11B1CYP11B2CYP17A1
SCHEMBL16805209 0.90 ESR1 (0.41) HSD17B1HSD17B2CYP11B1CYP11B2CYP17A1
SCHEMBL4407994 0.90 HSD17B1 (0.42) HSD17B1HSD17B2CYP11B1CYP11B2CYP17A1
SCHEMBL13007010 0.90 ESR1 (0.41) HSD17B1HSD17B2CYP11B1CYP11B2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230276706-A1 NOVEL HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DIODE INCLUDING SAME SFC CO., LTD. (KR) 2023-08-31 — — US disclosed
US-11723265-B2 Organic light emitting diode with high efficiency SFC CO., LTD. (KR) 2023-08-08 — — US disclosed
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME SFC CO., LTD. (KR) 2018-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276706-A1 NOVEL HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DIODE INCLUDING SAME CYBA, CYP1B1, PPOX HSD17B1 836/4885HSD17B2 838/4885CYP11B1 42/4885
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME CYP1B1, CYP1A1, CRY2 HSD17B1 1672/4885HSD17B2 1736/4885CYP11B1 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback